Prime Highlights-
- Medicover agrees to sell its India hospital business to KKR-backed funds in a deal valued at €1.2 billion.
- The sale lets Medicover sharpen its strategic and operational focus on core markets in Poland, Germany and Romania.
Key Facts-
- Medicover owns 66.1% of MHI, which posted €220.5 million in revenue.
- Deal brings Medicover €740 million in cash, closing expected in Q4 2026.
Background-
Medicover, the Swedish healthcare group, will sell its India hospital operations to funds run by investment firm KKR. The deal is worth €1.2 billion ($1.39 billion). Company executives said the move frees Medicover to concentrate on Poland, Germany and Romania, markets where it already runs a large network of clinics and hospitals.
Once the sale closes, Medicover stands to pocket €740 million in gross cash. Management noted that the company’s financial targets stay in place until the transaction wraps up. Officials expect the process to finish in the fourth quarter of 2026.
At the heart of the deal sits Medicover Hospitals India (MHI)Of MHI, Medicover owns 66.1% and minority investors hold 33.9%. The company’s revenue climbed to €220.5 million on a trailing twelve-month basis through June 2026, a sign of its growing footprint across India’s private hospital sector.
Medicover’s quarterly numbers show India made up a tenth of total group revenue during the second quarter of 2026. Even so, leadership decided to walk away from the segment, betting instead on deeper roots in Central and Eastern Europe, where the company has operated for years.
KKR gains a foothold in one of the world’s fastest-growing hospital markets through the purchase. Private equity firms have poured money into Indian healthcare in recent years, and this deal adds to that trend. Once finalized, KKR will run MHI’s hospital network outright, freeing Medicover to pour resources back into its established European base.